Re: Effects of rosiglitazone on hormonal profile and ovulatory function in Chinese women with polycystic ovary syndrome.
Chan
Louis Y
LY
Lau
Tze K
TK
Fung
Tze M
TM
Chow
Kam M
KM
D000328:Adult; D002681:China; D015331:Cohort Studies; D004305:Dose-Response Relationship, Drug; D004334:Drug Administration Schedule; D005260:Female; D005640:Follicle Stimulating Hormone / Q000378:metabolism*; D005500:Follow-Up Studies; D006801:Humans; D007986:Luteinizing Hormone / Q000378:metabolism*; D008597:Menstrual Cycle / Q000187:drug effects; D010060:Ovulation / Q000187:drug effects; D011085:Polycystic Ovary Syndrome / Q000175:diagnosis / Q000188:drug therapy*; D011374:Progesterone / Q000378:metabolism*; D011446:Prospective Studies; D000077154:Rosiglitazone; D012720:Severity of Illness Index; D045162:Thiazolidinediones / Q000627:therapeutic use*; D016896:Treatment Outcome
D045162:Thiazolidinediones; D000077154:Rosiglitazone; D011374:Progesterone; D007986:Luteinizing Hormone; D005640:Follicle Stimulating Hormone